Your browser doesn't support javascript.
loading
Targeting hypoxic microenvironment of pancreatic xenografts with the hypoxia-activated prodrug TH-302.
Lohse, Ines; Rasowski, Joanna; Cao, Pinjiang; Pintilie, Melania; Do, Trevor; Tsao, Ming-Sound; Hill, Richard P; Hedley, David W.
Afiliación
  • Lohse I; Ontario Cancer Institute and Campbell Family Cancer Research Institute, Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.
  • Rasowski J; Ontario Cancer Institute and Campbell Family Cancer Research Institute, Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.
  • Cao P; Ontario Cancer Institute and Campbell Family Cancer Research Institute, Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.
  • Pintilie M; Ontario Cancer Institute and Campbell Family Cancer Research Institute, Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.
  • Do T; Ontario Cancer Institute and Campbell Family Cancer Research Institute, Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.
  • Tsao MS; Department of Radiation Medicine Program, Toronto, Ontario, Canada.
  • Hill RP; Department of STTARR Innovation Center, Toronto, Ontario, Canada.
  • Hedley DW; Ontario Cancer Institute and Campbell Family Cancer Research Institute, Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.
Oncotarget ; 7(23): 33571-80, 2016 Jun 07.
Article en En | MEDLINE | ID: mdl-27248663

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Mostazas de Fosforamida / Hipoxia de la Célula / Microambiente Tumoral / Antineoplásicos / Nitroimidazoles Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Oncotarget Año: 2016 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Mostazas de Fosforamida / Hipoxia de la Célula / Microambiente Tumoral / Antineoplásicos / Nitroimidazoles Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Oncotarget Año: 2016 Tipo del documento: Article País de afiliación: Canadá